Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Molecular pathologic diagnosis in solid tumors. What is clinically relevant?].

M Werner1, A D Cabras, H Höfler

  • 1Institut für Allgemeine Pathologie und Pathologische Anatomie der Technischen Universität München.

Der Pathologe
|July 2, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimizing the pathological diagnosis of diffuse malignant peritoneal mesothelioma.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2025
Same author

Activation of the PI3K/AKT pathway correlates with prognosis in stage II colon cancer.

British journal of cancer·2014
Same author

MiR-221/-222 differentiate prognostic groups in advanced breast cancers and influence cell invasion.

British journal of cancer·2013
Same author

[Participation and support of clinical studies and other scientific investigations. Statement of the German Society for Pathology].

Der Pathologe·2013
Same author

A specific expression profile of heat-shock proteins and glucose-regulated proteins is associated with response to neoadjuvant chemotherapy in oesophageal adenocarcinomas.

British journal of cancer·2013
Same author

Cellular transformation by chemicals and oncogernes gene transfer and phenotypic changes.

Cytotechnology·2012

Molecular pathology assays offer limited clinical applications in solid tumors, primarily aiding therapy decisions in breast cancer (Her-2/new amplification) and sarcomas (translocations). Future applications may expand for detecting minimal residual disease and tumor dissemination.

Area of Science:

  • Oncology
  • Molecular Pathology
  • Genetics

Context:

  • Current clinical applications of molecular pathology assays in solid tumors are limited.
  • Key findings influencing therapy include Her-2/new amplification in breast cancer and specific translocations in sarcomas.
  • Mutation analysis of p53 and microsatellite analysis have niche roles in specific diagnoses and screenings.

Purpose:

  • To review the current clinical relevance of molecular pathology assays in solid tumors.
  • To highlight established and potential future applications of these assays.

Summary:

  • Molecular pathology assays have few established clinical uses in solid tumors.
  • Her-2/new amplification (breast cancer) and sarcoma translocations are key therapeutic indicators.

Related Experiment Videos

  • p53 mutation analysis and microsatellite analysis serve specific diagnostic and screening purposes.
  • Future applications include minimal residual disease detection and FISH analysis of bodily fluids.

    • Impact:

    • Provides a concise overview of molecular pathology's current and future role in solid tumor management.
    • Highlights the importance of specific molecular markers in guiding cancer treatment decisions.
    • Suggests the expanding utility of molecular diagnostics in oncology.